According to Sutro Biopharma's latest financial reports the company's current revenue (TTM) is $0.15 B. In 2022 the company made a revenue of $67.77 M an increase over the years 2021 revenue that were of $61.88 M.The revenue is the total amount of income that a company generates by the sale of goods or services. Unlike with the earnings no expenses are subtracted.
Year | Revenue | Change |
---|---|---|
2023 (TTM) | $0.15 B | 126.84% |
2022 | $67.77 M | 9.52% |
2021 | $61.88 M | 44.84% |
2020 | $42.72 M | -0.03% |
2019 | $42.73 M | 11.24% |
2018 | $38.41 M |
Company | Revenue | Revenue differencediff. | Country |
---|---|---|---|
OPKO Health
OPK | $0.86 B | 461.69% | ๐บ๐ธ USA |
Onconova Therapeutics ONTX | $0.22 M | -99.85% | ๐บ๐ธ USA |